Oxford Nanopore Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Employees
  • 441
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $116M
Latest Deal Amount
  • Investors
  • 18

Oxford Nanopore General Information

Description

Developer of a new generation of DNA/RNA sequencing technology designed to enable the analysis of any living thing, by any person, in any environment. The company has developed a nanopore DNA sequencing platform that is uniquely scalable from pocket-sized formats through to ultra-high-throughput devices, thereby offering researchers with real-time data analysis for rapid and dynamic insights.

Contact Information

Formerly Known As
Oxford NanoLabs
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Decision/Risk Analysis
Primary Office
  • Gosling Building
  • Edmund Halley Road, Oxford Science Park
  • Oxford OX4 4DQ
  • England, United Kingdom
+44 0845 000 0000

Oxford Nanopore Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford Nanopore Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
20. Later Stage VC 13-Oct-2020 $116M 00000 00.000 Completed Profitable
19. Later Stage VC 26-May-2020 00000 00000 00.000 Completed Profitable
18. Corporate 18-Oct-2018 000.00 00000 00.000 Completed Profitable
17. Later Stage VC 20-Mar-2018 00000 00000 00.000 Completed Profitable
16. Later Stage VC 12-Dec-2016 00000 00000 00.000 Completed Profitable
15. Later Stage VC 03-Aug-2015 00000 00000 00.000 Completed Profitable
14. Later Stage VC 26-Aug-2014 000.00 00000 00.000 Completed Profitable
13. Secondary Transaction - Private 15-Nov-2013 000.00 00000 00000 Completed Profitable
12. Later Stage VC 11-Oct-2013 $64.1M $239M 00000 Completed Profitable
11. Later Stage VC 03-May-2012 $54.6M $175M 00000 Completed Profitable
To view Oxford Nanopore’s complete valuation and funding history, request access »

Oxford Nanopore Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 00
Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.00
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 0,000,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 0,000,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 15 1,750,000 $0.001289 $51.56 $51.56 1x $51.56 5.27%
Ordinary 14 1,217,391 $0.001289 $37.06 $37.06 1x $37.06 3.67%
To view Oxford Nanopore’s complete cap table history, request access »

Oxford Nanopore Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a new generation of DNA/RNA sequencing technology designed to enable the analysis of any living thing, by a
Discovery Tools (Healthcare)
Oxford, United Kingdom
441 As of 2020
00000
0.000 0000-00-00
0000000000 0 00000

000000 0

mpor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
0000000000000
Cambridge, United Kingdom
00 As of 0000
000.00
00.00 0000-00-00
000000000 000.00

00000000

rehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat c
0000000000000
Fremont, CA
00 As of 0000
000.00
000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oxford Nanopore Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sphere Fluidics Venture Capital-Backed Cambridge, United Kingdom 00 000.00 000000000 000.00
00000000 000-00000 Corporate Backed or Acquired Fremont, CA 00 000.00 000000&0 000.00
000000000 00000000 Formerly VC-backed Billerica, MA 00 00000 000000&0 00000
0000000 Venture Capital-Backed San Diego, CA 000 00000 00000000000 00000
000 000000000 0000 Formerly VC-backed Tucson, AZ 000 00000 000000000 - 00000
You’re viewing 5 of 30 competitors. Get the full list »

Oxford Nanopore Executive Team (9)

Name Title Board Seat Contact Info
Gordon Sanghera Ph.D Co-Founder, Chief Executive Officer & Board Member
Clive Brown Chief Technology Officer & Board Member
John Milton Ph.D Chief Scientific Officer
Spike Willcocks Ph.D Co-Founder, Chief Business Development Officer & Board Member
Tim Cowper Vice President of Finance & Board Member
You’re viewing 5 of 9 executive team members. Get the full list »

Oxford Nanopore Board Members (10)

Name Representing Role Since
Alan Aubrey IP Group Board Member 000 0000
Clive Brown Oxford Nanopore Chief Technology Officer & Board Member 000 0000
Gordon Sanghera Ph.D Oxford Nanopore Co-Founder, Chief Executive Officer & Board Member 000 0000
Guy Harmelin MD Self Board Member 000 0000
John O'Higgins Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Oxford Nanopore Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oxford Nanopore Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
International Holding Company Corporation Minority 000 0000 000000 0
Railway Pension Investments Limited Partner Minority 000 0000 000000 0
Orient Exel Investment Holding Company Minority 000 0000 000000 0
Tencent Holdings Corporation Minority 000 0000 000000 0
Amgen Corporation Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »